Bharat Parenterals informs about outcome of board meeting

09 Feb 2022 Evaluate

In compliance of Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Bharat Parenterals has informed that that the Board of Directors of the Company in its meeting held on 09th February, 2022 has considered and approved the Unaudited Financial Results for the Quarter ended 31st December, 2021 and taken on record Limited Review Report issued by the Statutory Auditors of the Company. In this respect, the company enclosed: Unaudited Financial Results for the Quarter ended 31st December, 2021 and Limited Review Report on the said Financial Results. The meeting of Board of Directors commenced at 01.30 pm and concluded at 02:00 pm.

The above information is a part of company’s filings submitted to BSE.



Bharat Parenterals Share Price

1007.75 4.40 (0.44%)
20-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.45
Dr. Reddys Lab 1298.95
Cipla 1255.85
Zydus Lifesciences 890.60
Lupin 2322.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×